Rossella Menghini Selected Research

Genetic Predisposition to Disease (Genetic Predisposition)

2/2009	Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.
1/2004	G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rossella Menghini Research Topics

Disease

15	Inflammation (Inflammations) 04/2023 - 04/2005
13	Atherosclerosis 01/2020 - 10/2009
10	Insulin Resistance 01/2022 - 02/2006
7	Obesity 01/2022 - 10/2007
6	Type 2 Diabetes Mellitus (MODY) 04/2023 - 10/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2004
5	Hyperglycemia 05/2021 - 07/2002
4	Diabetic Nephropathies (Diabetic Nephropathy) 12/2021 - 12/2013
3	Dysbiosis 04/2023 - 01/2016
3	Glucose Intolerance 12/2022 - 12/2005
3	Fatty Liver 01/2022 - 01/2016
3	Atherosclerotic Plaque (Atheroma) 12/2013 - 10/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2007
2	Hypertension (High Blood Pressure) 11/2021 - 10/2015
2	Fibrosis (Cirrhosis) 05/2021 - 01/2021
2	Neoplasms (Cancer) 12/2019 - 01/2017
2	Myocardial Infarction 10/2015 - 04/2015
2	Genetic Predisposition to Disease (Genetic Predisposition) 02/2009 - 01/2004
1	Hypercholesterolemia 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	COVID-19 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Weight Gain 12/2021
1	Carotid Artery Diseases 11/2021
1	Diabetes Mellitus 11/2021
1	Renal Insufficiency (Renal Failure) 11/2021
1	Proteinuria 05/2021
1	Hypertrophy 01/2021
1	Albuminuria 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2018
1	Overweight 03/2017

Drug/Important Bio-Agent (IBA)

10	Insulin (Novolin)FDA Link 02/2018 - 07/2002
9	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 07/2003
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
8	Tissue Inhibitor of Metalloproteinase-3IBA 01/2017 - 12/2005
4	LipidsIBA 12/2022 - 02/2012
4	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 05/2021 - 12/2013
4	Peptide Hydrolases (Proteases)FDA Link 12/2019 - 02/2012
4	DisintegrinsIBA 01/2017 - 10/2009
4	Insulin ReceptorIBA 12/2011 - 07/2003
4	ADAM17 ProteinIBA 01/2010 - 12/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 09/2015
3	CollagenIBA 05/2021 - 01/2012
3	Tissue Inhibitor of MetalloproteinasesIBA 12/2019 - 02/2012
3	Metalloproteases (Metalloproteinases)IBA 01/2017 - 10/2009
3	Matrix Metalloproteinases (MMPs)IBA 10/2009 - 12/2005
2	Transcription Factors (Transcription Factor)IBA 12/2022 - 12/2007
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 02/2014
2	InterleukinsIBA 10/2021 - 06/2014
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 02/2018
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 12/2019 - 01/2017
2	Apolipoproteins E (ApoE)IBA 10/2015 - 08/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2007 - 12/2005
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2006 - 07/2002
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023
1	Blood Glucose (Blood Sugar)IBA 11/2023
1	insulin degludecIBA 04/2023
1	Liraglutide FDA Link 04/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2023
1	CholesterolIBA 01/2023
1	Arachidonic Acid (Vitamin F)IBA 01/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022
1	superoxide dismutase 2IBA 01/2022
1	AntioxidantsIBA 01/2022
1	Phospholipases A2 (Phospholipase A2)IBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	UbiquitinIBA 01/2022
1	TRAM 34IBA 12/2021
1	Untranslated RNA (Noncoding RNA)IBA 12/2021
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2021
1	Long Noncoding RNAIBA 12/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 12/2021
1	oxidized low density lipoproteinIBA 11/2021
1	C-Reactive ProteinIBA 11/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Interleukin-8 (Interleukin 8)IBA 10/2021
1	ResistinIBA 10/2021
1	Ramipril (Altace)FDA LinkGeneric 05/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2021
1	2- ((4- methylphenyl)sulfonyl)- 5- nitrofuranIBA 05/2021
1	VimentinIBA 05/2021
1	Lysine (L-Lysine)FDA Link 05/2021
1	Periodic AcidIBA 01/2021
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021
1	nephrinIBA 01/2021
1	NPHS2 proteinIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2020

Therapy/Procedure

3	Therapeutics 04/2023 - 11/2021
1	Drug Therapy (Chemotherapy) 11/2023
1	Phototherapy (Light Therapy) 12/2022
1	Injections 01/2021